Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

Launched by GEORGE WASHINGTON UNIVERSITY · Jun 26, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how using the Systane iLux system before cataract surgery can help people who have dry eye disease caused by meibomian gland dysfunction. The goal is to see if this treatment can improve dryness and comfort in the eyes for patients who are preparing for cataract surgery.

To join the study, participants need to be at least 18 years old and have a scheduled cataract surgery. They should be able to follow the study's instructions and visit schedule. However, individuals with certain eye conditions, recent eye surgeries, or specific eyelid problems may not be eligible to participate. Those who join can expect to receive the pre-operative treatment and will be monitored for its effects on their eye health. This study is currently recruiting participants, and everyone is welcome regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age greater than 18 at the time of informed consent
• • Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions
• • Upcoming scheduled senile cataract surgery
• Exclusion Criteria:
• • Eyelid abnormalities
• • Patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months
• • Ocular surgery within the last 6 months
• • Occlusion therapy with lacrimal or punctum plugs within the last 3 months
• • Patients with an ocular surface abnormality that may compromise corneal integrity
• • Patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months)
• • Patients with cicatricial lid margin disease
• • patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia
• • Patients with permanent makeup or tattoos on their eyelids.
• • Previous application/administration of Systane iLux or LipiFlow treatment